KLRS US Equity
Kalaris Therapeutics, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1754068 · FY ends Dec 31$4.15
+0.03 (+0.73%)
USD · as of 2026-08-21 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 412K |
| % of shares out | 1.7% |
| Days to cover | 1.0 |
| Δ vs 2026-07-15 | -20.9% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 411,651 | -20.9% | 1,046,871 | 1.0 |
| 2026-07-15 | 520,187 | +3.5% | 44,656 | 11.7 |
| 2026-06-30 | 502,578 | -34.1% | 93,575 | 5.4 |
| 2026-06-15 | 762,669 | -4.8% | 69,947 | 10.9 |
| 2026-05-29 | 801,523 | -0.3% | 77,879 | 10.3 |
| 2026-05-15 | 804,374 | -0.2% | 101,925 | 7.9 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
